Actively Recruiting

Age: 18Years - 99Years
All Genders
Healthy Volunteers
ID04525833

The Association of Liver Disease With Other Systemic Diseases Focusing on Disease Progression, Treatments, and Clinical Outcomes Using Hospital Data from Buddhist Tzu Chi Medical Foundation

Led by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation · Updated on 2025-09-19

15000

Participants Needed

1

Research Sites

52 weeks

Total Duration

On this page

Sponsors

T

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation

Lead Sponsor

D

Dalin Tzu Chi General Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating how chronic liver diseases such as hepatitis B, hepatitis C, alcoholic liver disease, fatty liver, liver cirrhosis, and hepatocellular carcinoma relate to other systemic diseases. This study aims to understand the impact of liver disorders on the progression, treatments, and prognosis of other body system diseases by analyzing existing hospital data collected by the Buddhist Tzu Chi Medical Foundation. Understanding these interactions is important for improving overall health and reducing public health burdens worldwide. This study uses a retrospective approach by reviewing data from the Hospital Database of Buddhist Tzu Chi Medical Foundation. It examines the effects of various systemic diseases on liver disease progression and vice versa. The study also explores different treatment approaches, including western medicine, traditional Chinese medicine, surgical methods, and other therapies, to see how they influence long-term health outcomes for patients with liver or systemic diseases. Participants' past medical records will be analyzed to evaluate the incidence of new liver complications such as hepatocellular carcinoma and liver cirrhosis events over up to 10 years. Researchers will monitor disease progression and treatment outcomes using these data. The study includes adults aged 18 to 99 who have visited the gastroenterology clinics at Tzu Chi Hospitals. Participation involves data review only, with no active treatment or visits required.

CONDITIONS

Brief Title

Liver Disease and Other Systemic Diseases

Who Can Participate

Age: 18Years - 99Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Individuals who visited the gastroenterology clinics of the Tzu Chi Hospitals, Buddhist Tzu Chi Medical Foundation
  • Age between 18 and 99 years
Not Eligible

You will not qualify if you...

  • Age younger than 18 years
  • Age older than 99 years

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Long-term Monitoring

Duration - Up to 120 months

Participants who undergo routine care for liver and systemic diseases are observed using hospital data to examine disease progression, treatments, and clinical outcomes.

Observations based on routine healthcare visits

Trial Site Locations

Total: 1 location

1

Ching-Sheng Hsu

New Taipei City, Taiwan, 23142

Actively Recruiting

Loading map...

Research Team

C

Ching-Sheng Hsu, Ph.D

C

Ching-Sheng Hsu

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Clinical Impact of 18F-FDGal PET/CT and PET/MRI in Patients ...

Hepatocellular Carcinoma

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan.

Chao-Chuan Wu, Chih-Wei Tseng, Kuo-Chih Tseng...

https://pubmed.ncbi.nlm.nih.gov/33288401